Regenxbio Inc (RGNX)

Jul 27, 2026

Diluted shares outstanding of REGENXBIO, Inc. – HAM:RB0 - TradingView

Jul 27, 2026

Jul 27, 2026

Regenxbio Inc (RGNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

Price to book ratio of REGENXBIO, Inc. – HAM:RB0 - TradingView

Jul 27, 2026

Jul 27, 2026

Inventory turnover of REGENXBIO, Inc. – HAM:RB0 - TradingView

Jul 27, 2026

Jul 27, 2026

Regenxbio Inc (RGNX) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Regenxbio Inc (RGNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026

Jul 26, 2026

Regenxbio Inc (RGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026

Jul 26, 2026

RGNX|Regenxbio Inc|Price:9.730|Chg%:-0.520 - TradingKey

Jul 26, 2026

Jul 25, 2026

FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy - Stocktwits

Jul 25, 2026

Jul 25, 2026

Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy - Stocktwits

Jul 25, 2026

Jul 24, 2026

RGNX Stock Slumps 15% After-Hours — What’s Driving The Selloff? - Stocktwits

Jul 24, 2026

Jul 24, 2026

REGENXBIO Inc. (RGNX) stock price, news, quote and history - Yahoo Finance Australia

Jul 24, 2026

Jul 24, 2026

REGENXBIO Inc. Revenue Breakdown – NASDAQ:RGNX - TradingView

Jul 24, 2026

Jul 24, 2026

Regenxbio Inc (RGNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 23, 2026

Matt Wilsey Built a Gene Therapy for His Daughter. He Says the FDA Isn't Ready for What Comes Next. - finance.biggo.com

Jul 23, 2026

Jul 23, 2026

REGENXBIO Inc. (RGNX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 23, 2026

Jul 21, 2026

Lawsuit alleges Regenxbio misled investors on g... - Pluang

Jul 21, 2026

Jul 21, 2026

Kuehn Law Encourages Investors of Regenxbio, Inc. to Contact Law Firm - Morningstar

Jul 21, 2026

Jul 21, 2026

RegenXBio Raises Capital Through Public Equity Offering - The Globe and Mail

Jul 21, 2026

Jul 20, 2026

(RGNX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jul 20, 2026

Jul 20, 2026

Clinical Trial Results Show Extended Benefits for REGENXBIO Retinal Treatments - Benzinga

Jul 20, 2026

Jul 20, 2026

REGENXBIO Raises $100 Million in Public Offering of Common Stock and Pre-Funded Warrants - Minichart

Jul 20, 2026

Jul 20, 2026

REGENXBIO (NASDAQ: RGNX) prices stock and warrant sale, netting $107.8M - Stock Titan

Jul 20, 2026

Jul 20, 2026

Regenxbio prices expected $100M public offering - The Pharma Letter

Jul 20, 2026

Jul 20, 2026

Regenxbio (RGNX) Reports Positive Long-Term Results for Gene The - GuruFocus

Jul 20, 2026

Jul 20, 2026

Frontier tech research, news & data - MLQ.ai

Jul 20, 2026

Jul 19, 2026

Regenxbio (RGNX) Reports Positive Long-Term Results for Gene Therapy in Eye Conditions - GuruFocus

Jul 19, 2026

Jul 18, 2026

Regenxbio reports 5-year wet AMD efficacy data for sura-vec gene therapy at ASRS meeting - Bitget

Jul 18, 2026

Jul 18, 2026

REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting - PR Newswire

Jul 18, 2026

Jul 18, 2026

RGNX Stock Sinks After $100M Equity Deal Hits Sentiment - timothysykes.com

Jul 18, 2026

Jul 18, 2026

REGENXBIO Stock Slides After $100M Equity Offering Pricing - timothysykes.com

Jul 18, 2026

Jul 18, 2026

REGENXBIO Stock Slides After $100M Equity Offering Shock - StocksToTrade

Jul 18, 2026

Jul 18, 2026

Form 424B5 Regenxbio Inc For: 17 July By Investing.com - Investing.com Australia

Jul 18, 2026

Jul 18, 2026

Regenxbio prices $100m public offering at $9 per share By Investing.com - Investing.com South Africa

Jul 18, 2026

Jul 18, 2026

Form 424B5 Regenxbio Inc For: 17 July - Investing.com UK

Jul 18, 2026

Jul 18, 2026

REGENXBIO (RGNX) Launches $100M Public Offering at $9.00 per Sha - GuruFocus

Jul 18, 2026

Jul 17, 2026

REGENXBIO stock dips on $100M equity offering - MSN

Jul 17, 2026

Jul 17, 2026

Regenxbio Shares Fall on $100M Stock, Pre-Funded Warrant Offering - Moomoo

Jul 17, 2026

Jul 17, 2026

REGENXBIO (NASDAQ: RGNX) launches $100M equity and pre-funded warrant raise - Stock Titan

Jul 17, 2026

Jul 17, 2026

Regenxbio (RGNX) Launches $100 Million Public Offering - GuruFocus

Jul 17, 2026

Jul 17, 2026

RGNX Stock Slides As $100M Offering And Legal Heat Hit - StocksToTrade

Jul 17, 2026

Jul 17, 2026

REGENXBIO Prices $100 Million Public Offering - Moomoo

Jul 17, 2026

Jul 17, 2026

Crude Oil Surges 4%; Travelers Posts Upbeat Q2 results - Benzinga

Jul 17, 2026

Jul 17, 2026

RGNX Stock Dips As Equity Offering And Litigation Raise Risk - timothysykes.com

Jul 17, 2026

Jul 17, 2026

REGENXBIO raises USD 100m amid pivotal year for gene therapy pipeline - AllSci

Jul 17, 2026

Jul 17, 2026

REGENXBIO files prospectus for up to $100M common stock offering - MSN

Jul 17, 2026

Jul 17, 2026

Gene Therapy Pioneer REGENXBIO Prices Public Offering, Aims to Raise $100 Million - finance.biggo.com

Jul 17, 2026

Jul 17, 2026

Regenxbio prices $100m public offering at $9 per share - Investing.com

Jul 17, 2026

Jul 17, 2026

REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants - PR Newswire

Jul 17, 2026

Jul 17, 2026

Why is Regenxbio stock falling sharply today? - Investing.com

Jul 17, 2026